U.S. hospital emergency department visits declined by an estimated 42% between March 29 and April 25 compared to a year ago, while visits for infectious disease screening or exposure were nearly four times higher, according to a report released today by the Centers for Disease Control and Prevention.

Overall ED visits declined to a weekly average of 1.2 million from 2.1 million the same period last year, based on data from hospitals in 47 states representing 73% of ED visits.

“The striking decline in ED visits nationwide, with the highest declines in regions where the pandemic was most severe in April 2020, suggests that the pandemic has altered the use of the ED by the public,” the authors said. “Persons who use the ED as a safety net because they lack access to primary care and telemedicine might be disproportionately affected if they avoid seeking care because of concerns about the infection risk in the ED.”

To minimize SARS-CoV-2 transmission risk and address public concerns about visiting the ED during the pandemic, the report recommends continued use of virtual visits and triage help lines and adherence to CDC infection control guidance.

Related News Articles

Headline
The Department of Health and Human Services Sept. 18 announced it will take new actions to help improve care for individuals with long COVID. They include a…
Headline
The Food and Drug Administration has identified a Class I recall for Mo-Vis BVBA R-net Joysticks due to a firmware error that causes the wheelchair to ignore…
Headline
The Centers for Disease Control and Prevention is predicting a similar combined number of peak hospitalizations from COVID-19, the flu and respiratory…
Headline
The Occupational Safety and Health Administration today announced a 60-day extension of the comment period on its proposed rule to remove the remaining…
Headline
COVID-19 infections are growing or likely growing in 45 states and not changing in five states, according to the latest data from the Centers for Disease…
Headline
The Food and Drug Administration July 15 announced a recall by Sandoz on certain lots of cefazolin, due to the lots being mislabeled as penicillin G potassium…